Source: NASDAQ Stocks / 04 May 2023 20:30:46 America/New_York
Fintel reports that on May 3, 2023, Barclays reiterated coverage of Hikma Pharmaceuticals (LSE:HIK) with a Equal Weight recommendation.
https://www.nasdaq.com/articles/barclays-reiterates-hikma-pharmaceuticals-lse:hik-equal-weight-recommendation